New treatment option for Parkinson Disease
Official title The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease
ClinicalTrials.gov ID: NCT06707402
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that is most effective. The main questions are: If brisk walking can reduce self-perceived walking difficulty What type of exercise intervention is most effective.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- clinically diagnosed with Parkinson's disease
- aged ≥40 years
- Hoehn and Yahr stage ≤3
- able to independently undertake transportation back and forth from test days and training sessions
- expectedly able to complete ≥85% of the training sessions
You likely can't join if
- have another neurological disorder or other disorders that affect gait and balance (e.g., severe arthritis or arthrosis)
- are pregnant
- have dementia (Montreal Cognitive Assessment score \<18)
- are suffering from alcohol abuse (i.e., exceeding ten units per week, according to the Danish Health Authority recommendation
- have cardiovascular, respiratory, orthopedic, or metabolic disorders or other medical comorbidities hindering participation in maximal exercise...
- have a depression
See the full eligibility criteria
- clinically diagnosed with Parkinson's disease
- aged ≥40 years
- Hoehn and Yahr stage ≤3
- able to independently undertake transportation back and forth from test days and training sessions
- expectedly able to complete ≥85% of the training sessions
- experience walking difficulties (the generic walking scale (Walk-12G) score ≥8.5).
- have another neurological disorder or other disorders that affect gait and balance (e.g., severe arthritis or arthrosis)
- are pregnant
- have dementia (Montreal Cognitive Assessment score \<18)
- are suffering from alcohol abuse (i.e., exceeding ten units per week, according to the Danish Health Authority recommendation
- have cardiovascular, respiratory, orthopedic, or metabolic disorders or other medical comorbidities hindering participation in maximal exercise testing.
- have a depression
- use an activity tracker during exercise
- performing high-intensity brisk walking three or more times during a week.
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus C, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus C, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.